BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

409 related articles for article (PubMed ID: 21240275)

  • 21. Biallelic inactivation of REV7 is associated with Fanconi anemia.
    Bluteau D; Masliah-Planchon J; Clairmont C; Rousseau A; Ceccaldi R; Dubois d'Enghien C; Bluteau O; Cuccuini W; Gachet S; Peffault de Latour R; Leblanc T; Socié G; Baruchel A; Stoppa-Lyonnet D; D'Andrea AD; Soulier J
    J Clin Invest; 2016 Sep; 126(9):3580-4. PubMed ID: 27500492
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Functional defects in the fanconi anemia pathway in pancreatic cancer cells.
    van der Heijden MS; Brody JR; Gallmeier E; Cunningham SC; Dezentje DA; Shen D; Hruban RH; Kern SE
    Am J Pathol; 2004 Aug; 165(2):651-7. PubMed ID: 15277238
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Compromised repair of radiation-induced DNA double-strand breaks in Fanconi anemia fibroblasts in G2.
    Zahnreich S; Weber B; Rösch G; Schindler D; Schmidberger H
    DNA Repair (Amst); 2020 Dec; 96():102992. PubMed ID: 33069004
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Elevated levels of STAT1 in Fanconi anemia group A lymphoblasts correlate with the cells' sensitivity to DNA interstrand crosslinking drugs.
    Prieto-Remón I; Sánchez-Carrera D; López-Duarte M; Richard C; Pipaón C
    Haematologica; 2013 May; 98(5):705-13. PubMed ID: 23585528
    [TBL] [Abstract][Full Text] [Related]  

  • 25. SLX4 Prevents GEN1-Dependent DSBs During DNA Replication Arrest Under Pathological Conditions in Human Cells.
    Malacaria E; Franchitto A; Pichierri P
    Sci Rep; 2017 Mar; 7():44464. PubMed ID: 28290553
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fanconi anemia and breast cancer susceptibility meet again.
    Levy-Lahad E
    Nat Genet; 2010 May; 42(5):368-9. PubMed ID: 20428093
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Analysis of SLX4/FANCP in non-BRCA1/2-mutated breast cancer families.
    Fernández-Rodríguez J; Quiles F; Blanco I; Teulé A; Feliubadaló L; Valle JD; Salinas M; Izquierdo A; Darder E; Schindler D; Capellá G; Brunet J; Lázaro C; Pujana MA
    BMC Cancer; 2012 Mar; 12():84. PubMed ID: 22401137
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Helicase-inactivating
    Kamal L; Pierce SB; Canavati C; Rayyan AA; Jaraysa T; Lobel O; Lolas S; Norquist BM; Rabie G; Zahdeh F; Levy-Lahad E; King MC; Kanaan MN
    Cold Spring Harb Mol Case Stud; 2020 Oct; 6(5):. PubMed ID: 33028645
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fanconi anemia with sun-sensitivity caused by a Xeroderma pigmentosum-associated missense mutation in XPF.
    Popp I; Punekar M; Telford N; Stivaros S; Chandler K; Minnis M; Castleton A; Higham C; Hopewell L; Gareth Evans D; Raams A; Theil AF; Meyer S; Schindler D
    BMC Med Genet; 2018 Jan; 19(1):7. PubMed ID: 29325523
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Direct interaction of the Fanconi anaemia protein FANCG with BRCA2/FANCD1.
    Hussain S; Witt E; Huber PA; Medhurst AL; Ashworth A; Mathew CG
    Hum Mol Genet; 2003 Oct; 12(19):2503-10. PubMed ID: 12915460
    [TBL] [Abstract][Full Text] [Related]  

  • 31. SLX4IP acts with SLX4 and XPF-ERCC1 to promote interstrand crosslink repair.
    Zhang H; Chen Z; Ye Y; Ye Z; Cao D; Xiong Y; Srivastava M; Feng X; Tang M; Wang C; Tainer JA; Chen J
    Nucleic Acids Res; 2019 Nov; 47(19):10181-10201. PubMed ID: 31495888
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Assessment of SLX4 Mutations in Hereditary Breast Cancers.
    Shah S; Kim Y; Ostrovnaya I; Murali R; Schrader KA; Lach FP; Sarrel K; Rau-Murthy R; Hansen N; Zhang L; Kirchhoff T; Stadler Z; Robson M; Vijai J; Offit K; Smogorzewska A
    PLoS One; 2013; 8(6):e66961. PubMed ID: 23840564
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Biallelic germline BRCA1 mutations in a patient with early onset breast cancer, mild Fanconi anemia-like phenotype, and no chromosome fragility.
    Keupp K; Hampp S; Hübbel A; Maringa M; Kostezka S; Rhiem K; Waha A; Wappenschmidt B; Pujol R; Surrallés J; Schmutzler RK; Wiesmüller L; Hahnen E
    Mol Genet Genomic Med; 2019 Sep; 7(9):e863. PubMed ID: 31347298
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Assessing the spectrum of germline variation in Fanconi anemia genes among patients with head and neck carcinoma before age 50.
    Chandrasekharappa SC; Chinn SB; Donovan FX; Chowdhury NI; Kamat A; Adeyemo AA; Thomas JW; Vemulapalli M; Hussey CS; Reid HH; Mullikin JC; Wei Q; Sturgis EM
    Cancer; 2017 Oct; 123(20):3943-3954. PubMed ID: 28678401
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Beyond interstrand crosslinks repair: contribution of FANCD2 and other Fanconi Anemia proteins to the replication of DNA.
    Federico MB; Campodónico P; Paviolo NS; Gottifredi V
    Mutat Res; 2018 Mar; 808():83-92. PubMed ID: 29031493
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Multiplexed CRISPR/Cas9-mediated knockout of 19 Fanconi anemia pathway genes in zebrafish revealed their roles in growth, sexual development and fertility.
    Ramanagoudr-Bhojappa R; Carrington B; Ramaswami M; Bishop K; Robbins GM; Jones M; Harper U; Frederickson SC; Kimble DC; Sood R; Chandrasekharappa SC
    PLoS Genet; 2018 Dec; 14(12):e1007821. PubMed ID: 30540754
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular defects identified by whole exome sequencing in a child with Fanconi anemia.
    Zheng Z; Geng J; Yao RE; Li C; Ying D; Shen Y; Ying L; Yu Y; Fu Q
    Gene; 2013 Nov; 530(2):295-300. PubMed ID: 23973728
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fanconi anemia pathway--the way of DNA interstrand cross-link repair.
    Yao CJ; Du W; Zhang Q; Zhang F; Zeng F; Chen FP
    Pharmazie; 2013 Jan; 68(1):5-11. PubMed ID: 23444773
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of Fanconi Anemia genes in familial breast cancer predisposition.
    Seal S; Barfoot R; Jayatilake H; Smith P; Renwick A; Bascombe L; McGuffog L; Evans DG; Eccles D; Easton DF; Stratton MR; Rahman N;
    Cancer Res; 2003 Dec; 63(24):8596-9. PubMed ID: 14695169
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of non-homologous end joining in Fanconi Anemia cells results in rescue of survival after interstrand crosslinks but sensitization to replication associated double-strand breaks.
    Eccles LJ; Bell AC; Powell SN
    DNA Repair (Amst); 2018 Apr; 64():1-9. PubMed ID: 29459202
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.